Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.12, 2009-12, pp. : 1017-1029

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized Phase II Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 802-816

Taylor & Francis Ltd

Access to resources Recommend Favorite

Understanding Site Performance Differences in Multinational Phase III Clinical Trials

By Glass Harold E. DiFrancesco Jeffrey J.

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 4, 2007-01 ,pp. : 279-286

Adis International

Access to resources Recommend Favorite

Randomized controlled clinical trials of experimental vaccines

By Naficy A.B. Clemens J.D. Rao M.R.

European Journal of Medicinal Chemistry, Vol. 95, Iss. 4, 1997-10 ,pp. : 187-196

Elsevier

Access to resources Recommend Favorite

Randomized Clinical Trials in Children - Ethical and Methodological Issues

Current Pharmaceutical Design, Vol. 16, Iss. 22, 2010-07 ,pp. : 2407-2415

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Intravascular Ultrasound in Clinical Trials

Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. : 24-34

Karger

Access to resources Recommend Favorite